Identification of a Person having Risk for Atherosclerosis and Associated Disease by the Person's Gut Microbiome and the Prevention of such Diseases
AssigneeMetabogen AB
InventorsFredrik Backhed, Fredrik H. Karlsson, Jens Nielsen
Life of this patent
Estimating the term…
Abstract
The present invention provides the use of metagenomics to identify a compositional or functional alteration of the gut metagenome related to atherosclerosis or atherosclerotic associated disease. Also provided are methods to identify a person having risk for atherosclerosis and associated diseases by determining the presence of specific bacterial groups or species and also metabolic functions in the person's gut microbiota and to use such information to develop a prevention or treatment strategy.
Claims5
1-47. (canceled)
A method of treating or preventing atherosclerosis or atherosclerotic associated disease in a subject having or being at risk of having atherosclerosis or atherosclerotic associated disease, comprising:
- administering an effective amount of n-carotene.
51-53. (canceled)
Dependencies are inferred from the claim text.